PARADIGM SPINE LLC

NEW YORK, NY · Medtech · Acquired

Spinal implant devices for spine surgery and fusion

Claim this profile

Follows are private to you and power your alerts

Updated · paradigmspine.com

Sector
Medtech
Headquarters
NEW YORK, NY
Latest Form D
$10M, Nov 2012
Total capital
$36.3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$36.3M
3 Form D · last Nov 2012
167 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
21
19 pending · first 2015
Rank in peer group#106 of 1112

Capital timeline

2009201020112012FEDERAL ↑EQUITY ↓Cumulative $36.3M1st Form D$23M2nd Form D$3.3M3rd Form D$10M
2009201020112012FEDERAL ↑EQUITY ↓Cumulative $36.3M1st Form D$23M3rd Form D$10M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$10M
  • Private capital raisedForm D · SEC · 2nd filing$3.3M
  • Private capital raisedForm D · SEC · 1st filing$23M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#106 · top 10%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Gary LoweryResearcherExecutive OfficerLinked by 1 patent
  • Anthony G ViscogliosiDirectorNamed in SEC Form D filings
  • Arthur G Steffee MDDirectorNamed in SEC Form D filings
  • Chris P HughesExecutive OfficerNamed in SEC Form D filings
  • David C RobbinsDirectorNamed in SEC Form D filings
  • Guntmar EisenExecutive OfficerNamed in SEC Form D filings
Show all 14 people
  • Hallett C MathewsExecutive Officer, DirectorNamed in SEC Form D filings
  • Hallett R MatthewsDirectorNamed in SEC Form D filings
  • James R PastenaDirectorNamed in SEC Form D filings
  • Jeffrey C LightcapDirectorNamed in SEC Form D filings
  • John C MoranDirectorNamed in SEC Form D filings
  • Joseph G GerardiExecutive OfficerNamed in SEC Form D filings
  • Marc R ViscogliosiExecutive Officer, DirectorNamed in SEC Form D filings
  • Steven C AmelioExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 21 granted of 40
Show all 40 patent records
  • MONTERIS MEDICAL HOLDINGS, INCSimilar federal contract value in Medtech · null in contracts
  • L37, LLCSimilar federal contract value in Medtech · null in contracts
  • Noxilizer IncSimilar federal contract value in Medtech · null in contracts
  • AIRXPANDERS INCSimilar federal contract value in Medtech · null in contracts
  • Mantara IncSimilar federal contract value in Medtech · null in contracts
  • SciLogica CorpSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .